Bruno, R.; Sensi, E.; Lupi, C.; Giordano, M.; Bernardini, L.; Vivaldi, C.; Fornaro, L.; Vasile, E.; Campani, D.; Fontanini, G.
Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series. Diagnostics 2021, 11, 1046.
https://doi.org/10.3390/diagnostics11061046
AMA Style
Bruno R, Sensi E, Lupi C, Giordano M, Bernardini L, Vivaldi C, Fornaro L, Vasile E, Campani D, Fontanini G.
Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series. Diagnostics. 2021; 11(6):1046.
https://doi.org/10.3390/diagnostics11061046
Chicago/Turabian Style
Bruno, Rossella, Elisa Sensi, Cristiana Lupi, Mirella Giordano, Laura Bernardini, Caterina Vivaldi, Lorenzo Fornaro, Enrico Vasile, Daniela Campani, and Gabriella Fontanini.
2021. "Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series" Diagnostics 11, no. 6: 1046.
https://doi.org/10.3390/diagnostics11061046
APA Style
Bruno, R., Sensi, E., Lupi, C., Giordano, M., Bernardini, L., Vivaldi, C., Fornaro, L., Vasile, E., Campani, D., & Fontanini, G.
(2021). Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series. Diagnostics, 11(6), 1046.
https://doi.org/10.3390/diagnostics11061046
